跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Teluvis Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Teluvis Plus
Approved
STANDARD
Teluvis Plus
Sandoz Grup Saglik Ürünleri Ilaclari San. Ve. Tic. A.S
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1c57cce5711b7121
Company
Sandoz Grup Saglik Ürünleri Ilaclari San. Ve. Tic. A.S
Type
Standard
Approval Details
Approval Id
1c57cce5711b7121
Drug Approval Philippines Name
Teluvis Plus
Product Name
Teluvis Plus
Registration Number
DRP-9479
Brand Name
Teluvis Plus
Generic Name
Telmisartan + Hydrochlorothiazide
Dosage Form
Film-Coated Tablet
Dosage Strength
80 mg/25 mg
Manufacturer
Sandoz Grup Saglik Ürünleri Ilaclari San. Ve. Tic. A.S
Importer
Sandoz Philippines Corporation
Distributor
Sandoz Philippines Corporation
Issuance Date
25 January 2021
Expiry Date
25 January 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1c57cce5711b7121
Type
Standard
Back to Philippines FDA Approvals